Coronavirus vaccine: India has the first corona vaccine based on m-RNA technology, despite the country seeing an increase in corona cases. Learn how it differs from the other coronavirus vaccinations available in India.
Coronavirus Vaccination: Late on Tuesday night in India, another corona vaccine received emergency approval. The Drug Controller of India (DCGI) gave the vaccine emergency approval on Tuesday night. Genova Biopharma, a firm based in Pune, produces this vaccine. A person must be older than 18 to receive this vaccination. This vaccine comes in two doses as well. It can be used after a 28-day break.
The vaccine will be stored at 2 to 8 degrees Celsius.
Keep this m-RNA vaccination between 2 and 8 °C. This will make carrying it much simpler. Genoa released a statement last month reporting the Phase-3 test of its vaccine. It was stated that 4000 individuals participated in the Phase 2 and Phase 3 studies for this vaccination.
What distinguishes the m-RNA vaccine from other types of vaccinations?
In India, Coveshield and Covaccine are currently being used widely to treat Corona. These vaccines contain weak or dead corona viruses, which, when ingested by the body, trigger an immunological response. In other words, following the administration of this vaccination, our body produces weapons against the coronavirus, which are already existing in the body and fight it anytime it assaults. However, the m-RNA vaccination does not function in this way. For the body to produce proteins, m-RNA is necessary. It creates the instructions for making proteins by reading the m-RNA genes. Cells degrade m-RNA once they have finished producing proteins. The vaccine’s m-RNA has no effect on the cells’ DNA.
How effective is the m-RNA vaccine?
m-RNA technology instructs our cells to produce proteins to combat viruses and bacteria when they attack our body. As a result, our immune system receives the essential proteins and our bodies produce antibodies. The fact that it can be modified more quickly than the remainder of the vaccine is its greatest benefit. In other words, it is a little simpler to shape it to the new variety. A vaccine developed using m-RNA technology has never before been produced in India.
| |
 YouTube | Click Here |
| Facebook Page | Click Here |
| Instagram | Click Here |
| Telegram Channel | Click Here |
| Google News | Click Here |
| Twitter | Click Here |
